Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu

December 2016

New Clinical Trials Advance Treatment, Diagnosis of Gynecologic Cancers

New Clinical Trials Advance Treatment, Diagnosis of Gynecologic Cancers

Wilmot offers the most extensive portfolio of clinical trials for gynecologic cancers in the region. In addition to large national treatment trials, Wilmot also offers trials that are available only in Rochester, including one that is evaluating potential molecular biomarkers to predict the risk of a pelvic mass becoming cancerous. 

No Longer Science Fiction, Immunotherapy Offers Second Chances to Patients, New Opportunities for Research

No Longer Science Fiction, Immunotherapy Offers Second Chances to Patients, New Opportunities for Research

Among today's most promising clinical developments, immunotherapy aims to boost, restore, or improve the body’s natural defenses to fight cancer.